Denali TherapeuticsDNLI
那斯達克 · USD
13.44
-0.39
(-2.82%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Denali TherapeuticsDNLI
13.44
-0.39
(-2.82%)
財務數據
損益表
- 0.10
- 0.35
- 2.94
- 0.01
- -
- -
- -
- -
- -
- -
- 188.93
- 241.74
- 736.98
- -99.57
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | 1,267 | 294,123 | 35,141 | 10,283 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | 1,267 | 294,123 | 35,141 | 10,283 |
營業費用 | - | - | - | - | - | 132,572 | 115,062 | 123,640 | 155,956 | 115,627 |
研發費用 | 116,227 | 99,787 | 98,238 | 91,399 | 107,016 | 107,803 | 89,737 | 97,520 | 128,816 | 92,111 |
推銷及管理費用 | 29,353 | 30,059 | 24,949 | 25,194 | 25,236 | 24,769 | 25,325 | 26,120 | 27,140 | 23,516 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -145,580 | -129,846 | -123,187 | -116,593 | -132,252 | -132,572 | -113,795 | 170,483 | -120,815 | -105,344 |
其他收入及費用 | 12,610 | 15,161 | 15,995 | 17,567 | 30,450 | 13,129 | 14,442 | 12,900 | 11,034 | 6,660 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -132,970 | -114,685 | -107,192 | -99,026 | -101,802 | -119,443 | -99,353 | 183,383 | -109,781 | -98,684 |
所得稅 | - | 68 | - | - | - | 30 | - | - | - | -6 |
稅後純益 | -132,970 | -114,753 | -107,192 | -99,026 | -101,802 | -119,473 | -99,353 | 183,383 | -109,781 | -98,678 |
基本每股稅後盈餘(元) | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.80 | -0.75 |
稀釋每股稅後盈餘(元) | -0.78 | -0.68 | -0.63 | -0.58 | -0.68 | -0.87 | -0.71 | 1.32 | -0.80 | -0.75 |
基本平均股數(千股) | 171222.00 | 170086.00 | 169456.00 | 168831.00 | 149404.00 | 138245.00 | 137644.00 | 137047.00 | 136524.00 | 132877.00 |
稀釋平均股數(千股) | 171222.00 | 170086.00 | 169456.00 | 168831.00 | 149404.00 | 138245.00 | 137644.00 | 140930.00 | 136524.00 | 132877.00 |
還原基本每股稅後盈餘(元) | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.80 | -0.75 |
還原稀釋每股稅後盈餘(元) | -0.78 | -0.68 | -0.63 | -0.58 | -0.68 | -0.87 | -0.71 | 1.32 | -0.80 | -0.75 |
還原基本平均股數(千股) | 171,222 | 170,086 | 169,456 | 168,831 | 149,404 | 138,245 | 137,644 | 137,047 | 136,524 | 132,877 |
還原稀釋平均股數(千股) | 171,222 | 170,086 | 169,456 | 168,831 | 149,404 | 138,245 | 137,644 | 140,930 | 136,524 | 132,877 |
EBITDA(千元) | -133,646 | -118,231 | -113,301 | -107,142 | -110,156 | -129,509 | -109,459 | 174,135 | -107,587 | -97,660 |